LOS ANGELES, Nov. 17, 2025 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), an innovator in vaping technology and precision dosing, and IKE Tech LLC ("IKE Tech"), a joint venture that includes Ispire as a founding partner, released statements following the U.S. Food and Drug Administration's (FDA) Congressional funding and directive to combat the illicit vape market. As part of the continuing resolution passed by Congress and signed by President Trump, the FDA is now requ ...